Florida Cancer Specialists & Research Institute Announces Pharmacy Leadership Appointments

In Partnership With:

Partner | Oncology Network Providers | <b>Florida Cancer Specialists & Research Institute</b>

Long-serving pharmacy executive, Ray Bailey, retired on December 31, 2022.

Ray Bailey, BPharm, RPh, Senior Vice President of Pharmacy Services for Florida Cancer Specialists & Research Institute, LLC, retired on December 31, 2022. Bailey joined the statewide practice in 2009 and has been instrumental in developing its comprehensive Pharmacy Services division.

Florida Cancer Specialists & Research Institute President & Managing Physician Michael Diaz, MD, said, “Ray’s influence in establishing Rx To Go, our in-house oral oncolytic specialty pharmacy, introducing biosimilars and steering the industry standard in quality measures will be his legacy at Florida Cancer Specialists & Research Institute, benefitting our practice and our patients for years to come.”

“Under Ray’s leadership, Florida Cancer Specialists & Research Institute has achieved recognition for providing an advanced level of high-quality pharmacy and disease management services to ensure our patients receive the medications and support they need to achieve optimal outcomes,” said Nathan H. Walcker, Florida Cancer Specialists & Research Institute Chief Executive Officer.

Florida Cancer Specialists & Research Institute is pleased to announce the following Pharmacy leadership appointments:

  • John Mills, Florida Cancer Specialists & Research Institute Vice President of Pharmacy & Centralized Procurement, will assume oversight for Rx To Go, with responsibility for pharmacy strategy, centralized procurement, practice engagement and business development.
  • Sree Challa, PharmD, RPh, CPh, Senior Director of Rx To Go, will be responsible for the day-to-day oversight of Rx to Go operations.
  • Austin Cox, PharmD, Senior Director of Trade Relations, will oversee pharmacy relationships, drug purchasing contracts and business development.
  • Kristen Boykin, PharmD, BCOP, BCPS, Director of Pharmacy Operations, will expand her responsibilities to encompass all aspects of Pharmacy Operations.

“These experienced and capable leaders will ensure that Florida Cancer Specialists & Research Institute remains world-class in providing effective cancer treatment options for our patients,” said Paul Chadwick, Florida Cancer Specialists & Research Institute Chief Procurement Officer. “They share a true passion and commitment to best-in-class standards for pharmacy management and quality improvement with a patient-centric, value-based focus.”

John Mills joined Florida Cancer Specialists & Research Institute in 2019 as Director of Payer Relations and Business Strategy. He was named Senior Director of Pharmacy the following year and promoted to his current role in July 2021. John has devised and implemented numerous impactful strategies to ensure organizational effectiveness and he has been influential in strengthening payer relationships, enabling more patients to be served and eliminating delays in treatment.

Sree Challa provides strategic leadership to Rx To Go for the execution of progressive strategies to drive change and fulfill the tactical goals and vision of Florida Cancer Specialists & Research Institute. An accomplished pharmacy professional with more than 20 years of experience in pharmacy management, policy, risk analysis and process implementation, he has an impressive resume of accomplishments in which he challenged organizations to be the best possible while maintaining the patient as priority. Sree joined the Rx To Go team in July 2021.

Austin Cox, PharmD joined Florida Cancer Specialists & Research Institute earlier this year. He works to develop strong relationships with pharmaceutical companies and other trade partners to meet the needs of Florida Cancer Specialists & Research Institute physicians and patients. Integrating his pharmacy and medical drug experience, Austin also provides leadership to ensure compliance with pharmacy and medical boards as well as OSHA and other regulatory standards for safe, efficient and cost-effective medication use across Florida Cancer Specialists & Research Institute’s nearly 100 clinic locations.

A talented and respected Board-certified oncology pharmacist, Kristen Boykin, PharmD, BCOP, BCPS joined Florida Cancer Specialists & Research Institute in 2018 as a Clinical Oncology Pharmacist. Kristen has brought a vast knowledge of pharmacy and operational excellence to the team and takes pride in providing quality support to Florida Cancer Specialists & Research Institute clinics and patients. She was promoted to Director of Pharmacy Operations in January 2021.